Effective induction of high-titer antibodies by viral vector vaccines.

Effective induction of high-titer antibodies by viral vector vaccines.

Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody res...

Bibliografiset tiedot
Päätekijät:	Draper, S, Moore, A, Goodman, A, Long, C, Holder, A, Gilbert, S, Hill, F, Hill, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2008

Samankaltaisia teoksia

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Tekijä: Biswas, S, et al.
Julkaistu: (2012)

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.
Tekijä: Draper, S, et al.
Julkaistu: (2009)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
Tekijä: Draper, S, et al.
Julkaistu: (2013)

Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria (vol 5, pg 95, 2009)
Tekijä: Draper, S, et al.
Julkaistu: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Tekijä: Biswas, S, et al.
Julkaistu: (2011)

NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
Tekijä: Goodman, A, et al.
Julkaistu: (2009)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity to bacterial, viral and parasitic antigens: increased durable cellular immunity with reduced immunodominance
Tekijä: Moore, A, et al.
Julkaistu: (2005)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
Tekijä: Forbes, E, et al.
Julkaistu: (2011)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
Tekijä: Goodman, A, et al.
Julkaistu: (2009)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
Tekijä: Kapulu, M, et al.
Julkaistu: (2010)

A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Tekijä: Laura B A Williams, et al.
Julkaistu: (2019-01-01)

Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants
Tekijä: Bliss, C, et al.
Julkaistu: (2016)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
Tekijä: Moore, A, et al.
Julkaistu: (2005)

Viral vectors as vaccine platforms: Deployment in sight
Tekijä: Rollier, C, et al.
Julkaistu: (2011)

Viral vectors as vaccine platforms: deployment in sight.
Tekijä: Rollier, C, et al.
Julkaistu: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Tekijä: Sumi Biswas, et al.
Julkaistu: (2011-01-01)

Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route
Tekijä: Carey, J, et al.
Julkaistu: (2014)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Tekijä: Ewer, K, et al.
Julkaistu: (2015)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
Tekijä: Draper, S, et al.
Julkaistu: (2005)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
Tekijä: Goodman, A, et al.
Julkaistu: (2011)

Prime-boost vectored malaria vaccines: progress and prospects.
Tekijä: Hill, A, et al.
Julkaistu: (2010)

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.
Tekijä: Hutchings, C, et al.
Julkaistu: (2005)

Viral vectors as vaccine platforms: from immunogenicity to impact
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2016)

Viral vectored transmission blocking vaccines against <it>Plasmodium falciparum</it>
Tekijä: Sinden Robert E, et al.
Julkaistu: (2010-10-01)

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.
Tekijä: Forbes, E, et al.
Julkaistu: (2012)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
Tekijä: Milicic, A, et al.
Julkaistu: (2017)

Viral vectors for malaria vaccine development.
Tekijä: Li, S, et al.
Julkaistu: (2007)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
Tekijä: Sarah Wilmschen, et al.
Julkaistu: (2019-09-01)

Low antibody titers against malaria vaccine candidates RH5, RIPR and CYRPA in naturally infected people in an endemic area of Mali
Tekijä: Draper, S, et al.
Julkaistu: (2018)

Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.
Tekijä: Douglas, A, et al.
Julkaistu: (2010)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
Tekijä: Vuola, J, et al.
Julkaistu: (2005)

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Tekijä: Daniel B. Reeves, et al.
Julkaistu: (2023-12-01)

Pneumococcal Antibody Titers
Tekijä: Pamella F. Abghari MD, et al.
Julkaistu: (2017-02-01)

Neutralizing antibody titers after COVID-19 vaccination
Tekijä: Safoora Shirani Shams Abadi, et al.
Julkaistu: (2024-11-01)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
Tekijä: Goodman, A, et al.
Julkaistu: (2010)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
Tekijä: Elias, S, et al.
Julkaistu: (2014)

Therapeutic Immunoglobulin Selected For High Antibody Titer to RSV Also Contains High Antibody Titers to Other Respiratory Viruses
Tekijä: Jordan eOrange
Julkaistu: (2015-08-01)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
Tekijä: Elias, S, et al.
Julkaistu: (2013)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
Tekijä: Goodman, A, et al.
Julkaistu: (2011)

Ovine Pasteurellosis Vaccine: Assessment of the Protective Antibody Titer and Recognition of the Prevailing Serotypes
Tekijä: M. T Qasim, et al.
Julkaistu: (2022-06-01)